fda removes semaglutide shortage list 2025 As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Ozempic and Wegovy officially moved

Convenience and Preference A major advantage of oral semaglutide is convenience no needles, no refrigeration, and daily use that fits easily into most routines

*Not a guarantee of results

Black market tactics and techniques include the following: The use of social media platforms to quickly sell these drugs at heavily discounted prices Illegal online pharmacies that operate without licensure The sales of drugs in nonmedical locations (gyms, hair salons) Illegal diversion of drugs through unapproved shipping channels

PubMed Silveira SQ, da Silva LM, de Campos Vieira Abib A, Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy

The variability in responses underscores the importance of personalized medical approaches and the need for ongoing monitoring and adjustment of treatment plans by healthcare professionals